US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist

25.400
+0.140+0.55%

Close Apr 26 16:00 ET

25.440
+0.040+0.16%

Post 19:59 ET

143.83BMarket Cap68.65P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Oct 1, 2023

(Q2)Jul 2, 2023

(Q1)Apr 2, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Oct 2, 2022

(Q2)Jul 3, 2022

(Q1)Apr 3, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-70.27%8.7B

-38.93%5.24B

-42.07%3.46B

-114.79%-1.21B

-81.49%1.21B

-11.10%29.27B

44.70%8.58B

-46.53%5.97B

-27.56%8.17B

6.54B

Net income from continuing operations

-93.08%2.17B

-166.69%-3.34B

-127.63%-2.39B

-76.31%2.34B

-29.50%5.56B

39.81%31.4B

39.77%5B

5.79%8.64B

69.56%9.88B

--7.88B

Depreciation and amortization

24.21%6.29B

9.94%1.67B

31.87%1.56B

33.87%1.57B

25.27%1.49B

-2.45%5.06B

13.78%1.52B

-11.78%1.18B

-10.17%1.18B

--1.19B

Deferred tax

8.55%-3.44B

-409.04%-1.86B

-282.26%-113M

23.42%-873M

74.24%-598M

12.32%-3.76B

46.56%-365M

101.65%62M

-1,627.27%-1.14B

---2.32B

Other non cash items

-970.00%-4.28B

-127.50%-3.07B

-228.00%-574M

-175.10%-537M

-124.45%-100M

91.48%-400M

-47.27%-1.35B

89.68%-175M

150.35%715M

--409M

Change In working capital

61.48%-2.17B

246.03%8.45B

73.85%-1.2B

-41.58%-3.92B

-654.38%-5.51B

-144.04%-5.64B

26.07%2.44B

-167.78%-4.59B

-151.38%-2.77B

---730M

-Change in receivables

32.95%347M

----

106.85%261M

----

-Change in inventory

-97.80%-1.17B

----

47.47%-591M

----

-Change in payables and accrued expense

-125.19%-300M

----

-4.11%1.19B

----

-Change in other current assets

85.29%-663M

----

-326.30%-4.51B

----

-Change in other current liabilities

141.06%595M

----

-107.74%-1.45B

----

-Change in other working capital

-80.18%-982M

----

53.26%-545M

----

Cash from discontinued investing activities

Operating cash flow

-70.27%8.7B

-38.94%5.24B

-42.15%3.46B

-114.79%-1.21B

-81.47%1.21B

-10.17%29.27B

45.11%8.58B

-44.83%5.97B

-27.69%8.17B

--6.54B

Investing cash flow

Cash flow from continuing investing activities

-104.50%-32.28B

-149.31%-11B

242.40%890M

-125.26%-25.49B

484.83%3.32B

29.96%-15.78B

-70.84%-4.41B

93.79%-625M

-39.10%-11.31B

567M

Net PPE purchase and sale

-20.74%-3.91B

-4.30%-1.04B

3.69%-810M

-21.70%-914M

-77.14%-1.14B

-19.37%-3.24B

0.10%-1B

-36.08%-841M

-39.85%-751M

---643M

Net business purchase and sale

-88.85%-43.43B

-158.79%-43.41B

--0

---25M

--0

---23B

---16.77B

--0

---6.23B

Net investment purchase and sale

128.06%15.24B

150.40%33.44B

137.14%1.35B

-129.11%-24.02B

-39.94%4.47B

134.24%6.68B

911.79%13.35B

60.29%-3.64B

-42.42%-10.49B

--7.45B

Net other investing changes

6.25%-180M

66.67%15M

413.51%348M

-580.52%-524M

-46.15%-19M

37.25%-192M

-86.15%9M

62.88%-111M

67.23%-77M

---13M

Cash from discontinued investing activities

Investing cash flow

-104.51%-32.28B

-149.34%-11B

241.63%888M

-125.27%-25.49B

484.66%3.32B

30.00%-15.78B

-70.53%-4.41B

93.78%-627M

-39.03%-11.31B

--567M

Financing cash flow

Cash flow from continuing financing activities

275.72%26.07B

208.51%5.44B

34.40%-3.78B

977.95%27.18B

57.88%-2.77B

-51.12%-14.83B

-49.66%-5.02B

-422.78%-5.76B

198.63%2.52B

-6.58B

Net issuance payments of debt

1,122.33%35.95B

379.98%7.78B

59.44%-1.43B

542.59%29.63B

98.25%-32M

-218.77%-3.52B

-103.74%-2.78B

-563.90%-3.52B

1,072.78%4.61B

---1.83B

Net common stock issuance

--0

---2B

--0

---2B

Cash dividends paid

-2.94%-9.25B

-3.12%-2.32B

-3.07%-2.31B

-3.16%-2.32B

-2.40%-2.3B

-2.91%-8.98B

-2.56%-2.25B

-2.75%-2.25B

-2.79%-2.24B

---2.25B

Net other financing activities

-88.66%-632M

-357.14%-18M

-840.00%-37M

-192.16%-141M

12.80%-436M

-2,193.75%-335M

-96.52%7M

-98.46%5M

53.00%153M

---500M

Cash from discontinued financing activities

Financing cash flow

275.72%26.07B

208.51%5.44B

34.40%-3.78B

978.33%27.17B

57.87%-2.77B

-51.12%-14.83B

-49.66%-5.02B

-423.25%-5.76B

198.55%2.52B

---6.58B

Net cash flow

Beginning cash position

-76.40%468M

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

8.66%1.98B

-34.22%1.34B

-24.57%1.82B

38.92%2.51B

--1.98B

Current changes in cash

284.37%2.49B

62.68%-315M

236.96%567M

177.21%481M

230.70%1.76B

-722.12%-1.35B

-3,416.67%-844M

-19.31%-414M

-203.15%-623M

--531M

Effect of exchange rate changes

75.76%-40M

96.15%-1M

55.56%-32M

92.42%-5M

-100.00%-2M

-179.66%-165M

3.70%-26M

-94.59%-72M

-1,420.00%-66M

---1M

End cash Position

523.29%2.92B

141.63%3.23B

47.92%2.7B

-11.58%2.22B

-76.40%468M

-34.22%1.34B

-24.57%1.82B

--2.51B

Free cash flow

-81.59%4.79B

-44.65%4.2B

-48.45%2.65B

-128.60%-2.12B

-98.76%73M

-12.85%26.03B

54.34%7.58B

-49.73%5.13B

-31.06%7.42B

--5.9B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Oct 1, 2023	(Q2)Jul 2, 2023	(Q1)Apr 2, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Oct 2, 2022	(Q2)Jul 3, 2022	(Q1)Apr 3, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-70.27%8.7B	-38.93%5.24B	-42.07%3.46B	-114.79%-1.21B	-81.49%1.21B	-11.10%29.27B	44.70%8.58B	-46.53%5.97B	-27.56%8.17B	6.54B
Net income from continuing operations	-93.08%2.17B	-166.69%-3.34B	-127.63%-2.39B	-76.31%2.34B	-29.50%5.56B	39.81%31.4B	39.77%5B	5.79%8.64B	69.56%9.88B	--7.88B
Depreciation and amortization	24.21%6.29B	9.94%1.67B	31.87%1.56B	33.87%1.57B	25.27%1.49B	-2.45%5.06B	13.78%1.52B	-11.78%1.18B	-10.17%1.18B	--1.19B
Deferred tax	8.55%-3.44B	-409.04%-1.86B	-282.26%-113M	23.42%-873M	74.24%-598M	12.32%-3.76B	46.56%-365M	101.65%62M	-1,627.27%-1.14B	---2.32B
Other non cash items	-970.00%-4.28B	-127.50%-3.07B	-228.00%-574M	-175.10%-537M	-124.45%-100M	91.48%-400M	-47.27%-1.35B	89.68%-175M	150.35%715M	--409M
Change In working capital	61.48%-2.17B	246.03%8.45B	73.85%-1.2B	-41.58%-3.92B	-654.38%-5.51B	-144.04%-5.64B	26.07%2.44B	-167.78%-4.59B	-151.38%-2.77B	---730M
-Change in receivables	32.95%347M	----	----	----	----	106.85%261M	----	----	----	----
-Change in inventory	-97.80%-1.17B	----	----	----	----	47.47%-591M	----	----	----	----
-Change in payables and accrued expense	-125.19%-300M	----	----	----	----	-4.11%1.19B	----	----	----	----
-Change in other current assets	85.29%-663M	----	----	----	----	-326.30%-4.51B	----	----	----	----
-Change in other current liabilities	141.06%595M	----	----	----	----	-107.74%-1.45B	----	----	----	----
-Change in other working capital	-80.18%-982M	----	----	----	----	53.26%-545M	----	----	----	----
Cash from discontinued investing activities	0					0
Operating cash flow	-70.27%8.7B	-38.94%5.24B	-42.15%3.46B	-114.79%-1.21B	-81.47%1.21B	-10.17%29.27B	45.11%8.58B	-44.83%5.97B	-27.69%8.17B	--6.54B
Investing cash flow
Cash flow from continuing investing activities	-104.50%-32.28B	-149.31%-11B	242.40%890M	-125.26%-25.49B	484.83%3.32B	29.96%-15.78B	-70.84%-4.41B	93.79%-625M	-39.10%-11.31B	567M
Net PPE purchase and sale	-20.74%-3.91B	-4.30%-1.04B	3.69%-810M	-21.70%-914M	-77.14%-1.14B	-19.37%-3.24B	0.10%-1B	-36.08%-841M	-39.85%-751M	---643M
Net business purchase and sale	-88.85%-43.43B	-158.79%-43.41B	--0	---25M	--0	---23B	---16.77B	--0	--0	---6.23B
Net investment purchase and sale	128.06%15.24B	150.40%33.44B	137.14%1.35B	-129.11%-24.02B	-39.94%4.47B	134.24%6.68B	911.79%13.35B	60.29%-3.64B	-42.42%-10.49B	--7.45B
Net other investing changes	6.25%-180M	66.67%15M	413.51%348M	-580.52%-524M	-46.15%-19M	37.25%-192M	-86.15%9M	62.88%-111M	67.23%-77M	---13M
Cash from discontinued investing activities
Investing cash flow	-104.51%-32.28B	-149.34%-11B	241.63%888M	-125.27%-25.49B	484.66%3.32B	30.00%-15.78B	-70.53%-4.41B	93.78%-627M	-39.03%-11.31B	--567M
Financing cash flow
Cash flow from continuing financing activities	275.72%26.07B	208.51%5.44B	34.40%-3.78B	977.95%27.18B	57.88%-2.77B	-51.12%-14.83B	-49.66%-5.02B	-422.78%-5.76B	198.63%2.52B	-6.58B
Net issuance payments of debt	1,122.33%35.95B	379.98%7.78B	59.44%-1.43B	542.59%29.63B	98.25%-32M	-218.77%-3.52B	-103.74%-2.78B	-563.90%-3.52B	1,072.78%4.61B	---1.83B
Net common stock issuance	--0	--0	--0	--0	--0	---2B	--0	--0	--0	---2B
Cash dividends paid	-2.94%-9.25B	-3.12%-2.32B	-3.07%-2.31B	-3.16%-2.32B	-2.40%-2.3B	-2.91%-8.98B	-2.56%-2.25B	-2.75%-2.25B	-2.79%-2.24B	---2.25B
Net other financing activities	-88.66%-632M	-357.14%-18M	-840.00%-37M	-192.16%-141M	12.80%-436M	-2,193.75%-335M	-96.52%7M	-98.46%5M	53.00%153M	---500M
Cash from discontinued financing activities
Financing cash flow	275.72%26.07B	208.51%5.44B	34.40%-3.78B	978.33%27.17B	57.87%-2.77B	-51.12%-14.83B	-49.66%-5.02B	-423.25%-5.76B	198.55%2.52B	---6.58B
Net cash flow
Beginning cash position	-76.40%468M	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	8.66%1.98B	-34.22%1.34B	-24.57%1.82B	38.92%2.51B	--1.98B
Current changes in cash	284.37%2.49B	62.68%-315M	236.96%567M	177.21%481M	230.70%1.76B	-722.12%-1.35B	-3,416.67%-844M	-19.31%-414M	-203.15%-623M	--531M
Effect of exchange rate changes	75.76%-40M	96.15%-1M	55.56%-32M	92.42%-5M	-100.00%-2M	-179.66%-165M	3.70%-26M	-94.59%-72M	-1,420.00%-66M	---1M
End cash Position	523.29%2.92B	523.29%2.92B	141.63%3.23B	47.92%2.7B	-11.58%2.22B	-76.40%468M	-76.40%468M	-34.22%1.34B	-24.57%1.82B	--2.51B
Free cash flow	-81.59%4.79B	-44.65%4.2B	-48.45%2.65B	-128.60%-2.12B	-98.76%73M	-12.85%26.03B	54.34%7.58B	-49.73%5.13B	-31.06%7.42B	--5.9B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall